Collectively, these data position GLP-1R signaling as a metabolic-cognitive interface linking internal energy status to reward processing, affective regulation, and memory, and highlight the importance of disentangling direct central actions from indirect secondary metabolic effects when evaluating the therapeutic potential of GLP-1-based interventions for psychiatric and cognitive disorders. The gene discussed is GLP1R; the disease is Cognitive impairment.